Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started.

International journal of immunogenetics - 1 Apr 2021

Ivanova Milena, Shivarov Velizar

Abstract excerpt

The implementation of the immune checkpoint blockade as a therapeutic option in contemporary oncology is one of the significant immunological achievements in the last century. Constantly accumulating evidence suggests that the response to immune checkpoint inhibitors (ICIs) is not universal. Therefore, it is critical to identify determinants for response, resistance and adverse effects of immune checkpoint...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to Antineoplastic Agents, Immunological

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to B7-H1 Antigen

Share to Genes, MHC Class I

Share to Immune Checkpoint Inhibitors

Share to Programmed Cell Death 1 Receptor

Share to Self Tolerance

Share to Tumor Escape

Source

Identifiers

PMID: 33112034
DOI: 10.1111/iji.12517

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started.PMID 33112034Read ↗

Review – The impact of pharmacogenetics on the outcome of immune checkpoint inhibitorsSemantic proximity Read ↗

HLA Genotype is Associated With Clinical Outcomes to anti-PD1 Therapy in Advanced MelanomaSemantic proximity Read ↗

Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer PatientsSemantic proximity Read ↗

The HLA-I landscape confers prognosis and antitumor immunity in breast cancer.Semantic proximity Read ↗

Genotyping Natural Killer Immune Checkpoints to Discover Biomarkers of Response.Semantic proximity Read ↗

HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.Semantic proximity Read ↗

Pan-Cancer HLA Gene-Mediated Tumor Immunogenicity and Immune EvasionSemantic proximity Read ↗

Pan-cancer HLA Gene-mediated Tumor Immunogenicity and Immune EvasionSemantic proximity Read ↗

Assessment of cancer cell‐expressed HLA class I molecules and their immunopathological implicationsSemantic proximity Read ↗

Association between germ-line HLA and immune-related adverse eventsSemantic proximity Read ↗

Immune checkpoints and cancer in the immunogenomics eraSemantic proximity Read ↗

Response to Immune Checkpoint Blockade is Influenced by HLA-I Genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.